RE: The only way is up.26 Jan 2022 11:03
Last year SAR had high net worth investor buying at a much, much higher price (see below from RNS) - since then SAR has picked up fancy new broker, is pushing product into Covid development and now Sierra is falling into place. And never mind a growing bullishness for their specific area of science and research....and we're still on a low despite today's rise.
"Cambridge, UK, 9 August 2021 - Sareum Holdings plc (AIM: SAR), the specialist drug development company, announces that it has raised £1,000,000, before expenses, through a subscription by a high net worth individual (the "Subscriber") for 12,121,212 new ordinary shares of 0.025p each in the capital of the Company ("Ordinary Shares") (the "Subscription Shares") at a price of 8.25p per share (the "Subscription Price") (the "Subscription")."